Amy M. Crisp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy M. Crisp has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Christopher G. Morris
Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL
2 shared publications Aaron J. Katz
Department of Population Health, University of Kansas Medical Center, Kanas City, KS
1 shared publicationAdeel Markatia
Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida
1 shared publication- Ana-Maria Iosif
Department of Public Health Sciences, University of California, Davis, Davis, USA
1 shared publication Carla L. Fisher
Department of Health Outcomes & Biomedical Informatics, University of Florida College of Medicine, Gainesville, Florida
1 shared publicationCharles Griggs
COMPPARE Coordinating Center, Jacksonville, FL
1 shared publication
Latest Publications
- 29 July 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 126 (4) , 1339-1344
Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from Comparative Study of Proton and Photon Therapy in Prostate Cancer: A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer
- 29 July 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 126 (4) , 1339-1344
Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from Comparative Study of Proton and Photon Therapy in Prostate Cancer: A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer
- 19 July 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (5) , 1277-1284
Association Between Brain Substructure Dose and Scholastic Performance in Pediatric Brain Tumor Survivors Who Received Radiation Therapy
- 19 July 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (5) , 1277-1284
Association Between Brain Substructure Dose and Scholastic Performance in Pediatric Brain Tumor Survivors Who Received Radiation Therapy
- Open Access
- 22 January 2025
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 25 (1) , 1-10
Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes
Background: Cluster randomized trials, which often enroll a small number of clusters, can benefit from constrained randomization, selecting a final randomization scheme from a set of known, balanced randomizations. Previous literature has addressed the suitability of adjusting the analysis for the covariates that were balanced in the design phase when the outcome is continuous or binary. Here we extended this work to time-to-event outcomes by comparing two model-based tests and a newly derived permutation test. A current cluster randomized trial of vector control for the prevention of mosquito-borne disease in children in Mexico is used as a motivating example. Methods: We assessed type I error rates and power between simple randomization and constrained randomization using both prognostic and non-prognostic covariates via a simulation study. We compared the performance of a semi-parametric Cox proportional hazards model with robust variance, a mixed effects Cox model, and a permutation test utilizing deviance residuals. Results: The permutation test generally maintained nominal type I error—with the exception of the unadjusted analysis for constrained randomization—and also provided power comparable to the two Cox model-based tests. The model-based tests had inflated type I error when there were very few clusters per trial arm. All three methods performed well when there were 25 clusters per trial arm, as in the case of the motivating example. Conclusion: For time-to-event outcomes, covariate-constrained randomization was shown to improve power relative to simple randomization. The permutation test developed here was more robust to inflation of type I error compared to model-based tests. Gaining power by adjusting for covariates in the analysis phase was largely dependent on the number of clusters per trial arm.
- 22 January 2025
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 25 (1) , 1-10
Open AccessAnalysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes
Background: Cluster randomized trials, which often enroll a small number of clusters, can benefit from constrained randomization, selecting a final randomization scheme from a set of known, balanced randomizations. Previous literature has addressed the suitability of adjusting the analysis for the covariates that were balanced in the design phase when the outcome is continuous or binary. Here we extended this work to time-to-event outcomes by comparing two model-based tests and a newly derived permutation test. A current cluster randomized trial of vector control for the prevention of mosquito-borne disease in children in Mexico is used as a motivating example. Methods: We assessed type I error rates and power between simple randomization and constrained randomization using both prognostic and non-prognostic covariates via a simulation study. We compared the performance of a semi-parametric Cox proportional hazards model with robust variance, a mixed effects Cox model, and a permutation test utilizing deviance residuals. Results: The permutation test generally maintained nominal type I error—with the exception of the unadjusted analysis for constrained randomization—and also provided power comparable to the two Cox model-based tests. The model-based tests had inflated type I error when there were very few clusters per trial arm. All three methods performed well when there were 25 clusters per trial arm, as in the case of the motivating example. Conclusion: For time-to-event outcomes, covariate-constrained randomization was shown to improve power relative to simple randomization. The permutation test developed here was more robust to inflation of type I error compared to model-based tests. Gaining power by adjusting for covariates in the analysis phase was largely dependent on the number of clusters per trial arm.
What is it that you say you do here? Advocating for the critical role of data scientists in research infrastructure
Clinical and academic research continues to become more complex as our knowledge and technology advance. A substantial and growing number of specialists in biostatistics, data science and library sciences are needed to support these research systems and promote high‐calibre research. However, that support is often marginalized as optional rather than a fundamental component of research infrastructure. By building research infrastructure, an institution harnesses access to tools and support/service centres that host skilled experts who approach research with best practices in mind and domain‐specific knowledge at hand. We outline the potential roles of data scientists and statisticians in research infrastructure and recommend guidelines for advocating for the institutional resources needed to support these roles in a sustainable and efficient manner for the long‐term success of the institution. We provide these guidelines in terms of resource efficiency, monetary efficiency and long‐term sustainability. We hope this work contributes to—and provides shared language for—a conversation on a broader framework beyond metrics that can be used to advocate for needed resources.
What is it that you say you do here? Advocating for the critical role of data scientists in research infrastructure
Clinical and academic research continues to become more complex as our knowledge and technology advance. A substantial and growing number of specialists in biostatistics, data science and library sciences are needed to support these research systems and promote high‐calibre research. However, that support is often marginalized as optional rather than a fundamental component of research infrastructure. By building research infrastructure, an institution harnesses access to tools and support/service centres that host skilled experts who approach research with best practices in mind and domain‐specific knowledge at hand. We outline the potential roles of data scientists and statisticians in research infrastructure and recommend guidelines for advocating for the institutional resources needed to support these roles in a sustainable and efficient manner for the long‐term success of the institution. We provide these guidelines in terms of resource efficiency, monetary efficiency and long‐term sustainability. We hope this work contributes to—and provides shared language for—a conversation on a broader framework beyond metrics that can be used to advocate for needed resources.
- 17 March 2023
- Published by SAGE Publications in Clinical Trials
- Vol. 20 (3) , 284-292
Covariate-constrained randomization with cluster selection and substitution
Background: An ongoing cluster-randomized trial for the prevention of arboviral diseases utilizes covariate-constrained randomization to balance two treatment arms across four specified covariates and geographic sector. Each cluster is within a census tract of the city of Mérida, Mexico, and there were 133 eligible tracts from which to select 50. As some selected clusters may have been subsequently found unsuitable in the field, we desired a strategy to substitute new clusters while maintaining covariate balance. Methods: We developed an algorithm that successfully identified a subset of clusters that maximized the average minimum pairwise distance between clusters in order to reduce contamination and balanced the specified covariates both before and after substitutions were made. Simulations: Simulations were performed to explore some limitations of this algorithm. The number of selected clusters and eligible clusters were varied along with the method of selecting the final allocation pattern. Conclusion: The algorithm is presented here as a series of optional steps that can be added to the standard covariate-constrained randomization process in order to achieve spatial dispersion, cluster subsampling, and cluster substitution. Simulation results indicate that these extensions can be used without loss of statistical validity, given a sufficient number of clusters included in the trial.
- 17 March 2023
- Published by SAGE Publications in Clinical Trials
- Vol. 20 (3) , 284-292
Covariate-constrained randomization with cluster selection and substitution
Background: An ongoing cluster-randomized trial for the prevention of arboviral diseases utilizes covariate-constrained randomization to balance two treatment arms across four specified covariates and geographic sector. Each cluster is within a census tract of the city of Mérida, Mexico, and there were 133 eligible tracts from which to select 50. As some selected clusters may have been subsequently found unsuitable in the field, we desired a strategy to substitute new clusters while maintaining covariate balance. Methods: We developed an algorithm that successfully identified a subset of clusters that maximized the average minimum pairwise distance between clusters in order to reduce contamination and balanced the specified covariates both before and after substitutions were made. Simulations: Simulations were performed to explore some limitations of this algorithm. The number of selected clusters and eligible clusters were varied along with the method of selecting the final allocation pattern. Conclusion: The algorithm is presented here as a series of optional steps that can be added to the standard covariate-constrained randomization process in order to achieve spatial dispersion, cluster subsampling, and cluster substitution. Simulation results indicate that these extensions can be used without loss of statistical validity, given a sufficient number of clusters included in the trial.